Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion
about
Mechanisms of disease: Helicobacter pylori virulence factorsPathogenesis of Helicobacter pylori infectionVacA's Induction of VacA-Containing Vacuoles (VCVs) and Their Immunomodulatory Activities on Human T CellsAn Overview of Helicobacter pylori VacA Toxin BiologyNew Insights into VacA Intoxication Mediated through Its Cell Surface ReceptorsHelicobacter pylori Diversity and Gastric Cancer RiskHelicobacter pylori and T Helper Cells: Mechanisms of Immune Escape and ToleranceMetalloregulation of Helicobacter pylori physiology and pathogenesisHelicobacter pylori in gastric carcinogenesis: mechanismsTransforming growth factor-β: an important mediator in Helicobacter pylori-associated pathogenesisPattern-recognition receptors and gastric cancerHelicobacter pylori gamma-glutamyl transpeptidase and its pathogenic roleThe Immunomodulator VacA Promotes Immune Tolerance and Persistent Helicobacter pylori Infection through Its Activities on T-Cells and Antigen-Presenting CellsHelicobacter genotyping and detection in peroperative lavage fluid in patients with perforated peptic ulcerRandom mutagenesis of Helicobacter pylori vacA to identify amino acids essential for vacuolating cytotoxic activity.Helicobacter pylori VacA toxin promotes bacterial intracellular survival in gastric epithelial cells.Direct inhibition of T-cell responses by the Cryptococcus capsular polysaccharide glucuronoxylomannan.Analysis of a beta-helical region in the p55 domain of Helicobacter pylori vacuolating toxin.Silicon photonic microring resonators for quantitative cytokine detection and T-cell secretion analysis.ESAT-6 inhibits production of IFN-gamma by Mycobacterium tuberculosis-responsive human T cellsComparison of Helicobacter pylori virulence gene expression in vitro and in the Rhesus macaque.Characterization of the Helicobacter pylori cysteine-rich protein A as a T-helper cell type 1 polarizing agent.Reconstitution of Helicobacter pylori VacA toxin from purified componentsHelicobacter pylori and gastric cancer: factors that modulate disease risk.Prevention of Gastric Cancer: When is Treatment of Helicobacter Pylori Warranted?Immune evasion strategies used by Helicobacter pylori.Role of innate immunity in Helicobacter pylori-induced gastric malignancy.Geographic differences in gastric cancer incidence can be explained by differences between Helicobacter pylori strains.Regulation of murine dendritic cell immune responses by Helicobacter felis antigen.Effects of Helicobacter suis γ-glutamyl transpeptidase on lymphocytes: modulation by glutamine and glutathione supplementation and outer membrane vesicles as a putative delivery route of the enzymeRole of childhood infection in the sequelae of H. pylori diseaseHelicobacter pylori vacA s1a and s1b alleles from clinical isolates from different regions of Chile show a distinct geographic distribution.Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defensesHelicobacter pylori: Genomic Insight into the Host-Pathogen Interaction.Role of gastric epithelial cell-derived transforming growth factor beta in reduced CD4+ T cell proliferation and development of regulatory T cells during Helicobacter pylori infection.the versatility of the Helicobacter pylori vacuolating cytotoxin vacA in signal transduction and molecular crosstalk.H. pylori exploits and manipulates innate and adaptive immune cell signaling pathways to establish persistent infection.In vivo expression of Helicobacter pylori virulence genes in patients with gastritis, ulcer, and gastric cancer.Interaction of Helicobacter pylori with C-type lectin dendritic cell-specific ICAM grabbing nonintegrinSystems-wide analyses of mucosal immune responses to Helicobacter pylori at the interface between pathogenicity and symbiosis
P2860
Q24632788-94E1C9AC-4BD5-456E-951C-F8E69B35553BQ24679810-5FBFE453-7DD3-4839-BF60-9C352DBB661CQ26744316-92664CA7-731A-4620-A8F0-F8774D019095Q26748278-D7BFE5BE-0DFB-4985-B5D5-0F3739FAD025Q26748950-A03FDA64-0301-4625-BA7E-0D1FAFBDC510Q26774217-EA36B07B-D705-4937-8976-D39400064901Q26777418-6D4F6A83-B13B-4FDD-9CC5-85C2419DB040Q26782921-08675F3E-E53F-40AA-8346-C9DEB7F2E61EQ26821843-63430B3F-F2DA-4BEF-B407-F1313794ED8AQ26852779-0DF59C18-77F8-443E-B6EA-10393FCD62E8Q26991941-61DD34BC-47D5-4AFC-9555-519E9CF639A6Q27022681-B98984FF-D3BF-45C7-B895-FBF34F18312DQ28067015-6122CA3E-BAE5-4632-8967-B8B40CA10377Q28222358-6246C135-70F7-46FF-9D82-9702CEBD3516Q30445265-FB67F872-CEAB-4159-965B-4FEC1BD766B6Q30478466-35908F0D-2E77-41C3-99B8-D945F67DA408Q33263249-FD37F8A9-F4A2-4F30-A23B-E39B9949F20CQ33533647-F705F736-CD67-4BCA-94D0-94446EAD0D94Q33745408-3A36DC88-7E9A-4C63-8574-027240CD02BCQ33846096-03520CDE-20B4-47E9-9C20-28E924271141Q33946722-4CE9B691-97B4-4590-BEAB-0F0BF6A5EEE9Q33946782-21AB5AFD-8405-4E1D-918C-964D3B5CB188Q34020343-7193EA5C-BA91-4595-93E9-4775F432A50BQ34189885-08D49A02-189A-4D71-AF0C-36699805E5BAQ34197057-5A701870-1CD9-4315-B845-D9DDC3429860Q34255412-CAE87ACC-90E6-4BE2-99FD-ECEE961E0E10Q34343194-8DC7C2BD-DD83-41BB-B830-0E161FD30C05Q34593167-A392B5FA-ADB4-4835-8B87-6384DCF3E088Q34975720-682BB252-0F46-4362-B4B8-D509D7DB32B7Q35023497-48B1418F-D92D-4892-A187-2E898D1B14EBQ35052635-C1446F3C-E7F4-453F-AD38-8351049C6283Q35059571-F4BE6537-7A83-4B3F-8747-90C954292B1AQ35070861-0675DBF3-89B7-4867-BC82-45B509B91A58Q35101934-67CEA1C0-F5B4-4EE4-BD82-6AF7B6711C40Q35328508-46FB16EC-FAE3-4BBA-BA7A-84209441C521Q35506793-5120AEDB-A17A-4DC1-8451-D313B73A4A2CQ35544284-62A02A18-EDA2-4F9B-86D7-19AE995A5A6EQ35689522-5D8CA409-5715-4897-97C0-AF4962BFD1E1Q35894070-6524B486-44F0-4B43-AFCA-D58FF36F2E6FQ35945226-22B9DABE-2715-4E8D-9211-4FEB95734D9F
P2860
Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Inhibition of primary human T ...... VacA effects on IL-2 secretion
@ast
Inhibition of primary human T ...... VacA effects on IL-2 secretion
@en
Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin
@nl
type
label
Inhibition of primary human T ...... VacA effects on IL-2 secretion
@ast
Inhibition of primary human T ...... VacA effects on IL-2 secretion
@en
Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin
@nl
prefLabel
Inhibition of primary human T ...... VacA effects on IL-2 secretion
@ast
Inhibition of primary human T ...... VacA effects on IL-2 secretion
@en
Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin
@nl
P2860
P356
P1476
Inhibition of primary human T ...... VacA effects on IL-2 secretion
@en
P2093
Derya Unutmaz
Mark S Sundrud
P2860
P304
P356
10.1073/PNAS.0401528101
P407
P577
2004-05-05T00:00:00Z